Gerry91 Schumm995
=================
Race:                Native
Ethnicity:           Non-Hispanic
Gender:              M
Age:                 29
Birth Date:          1993-10-23
Marital Status:      M
--------------------------------------------------------------------------------
ALLERGIES:
  2018-12-13 : Sulfamethoxazole / Trimethoprim
  2018-12-13 : Allergy to substance (finding)
--------------------------------------------------------------------------------
ENCOUNTER
2022-09-25 : Encounter at VHS ACQUISITION SUBSIDIARY NUMBER 9, INC. : Encounter for Allergy to substance (finding)
Type: ambulatory
   
   MEDICATIONS:
   
   CONDITIONS:
   
   CARE PLANS:
   
   REPORTS:
   
   OBSERVATIONS:
   
   PROCEDURES:
  2022-09-25 : Subcutaneous immunotherapy
   
   IMMUNIZATIONS:
   
   IMAGING STUDIES:
   
--------------------------------------------------------------------------------
CONTINUING
   
   CONDITIONS:
  2022-04-02 : Full-time employment (finding)
  2020-03-21 : Stress (finding)
  2015-02-21 : Has a criminal record (finding)
  2014-02-03 : Chronic low back pain (finding)
  2014-02-03 : Chronic pain (finding)
  2011-12-17 : Received higher education (finding)
   
   MEDICATIONS:
  2022-04-02 : Acetaminophen 325 MG / Oxycodone Hydrochloride 10 MG Oral Tablet [Percocet]
  2018-12-13 : NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector
  2018-12-13 : cetirizine hydrochloride 10 MG Oral Tablet
  2018-11-30 + Hydrocortisone 10 MG/ML Topical Cream for Contact dermatitis
  2014-03-29 : Acetaminophen 300 MG / Hydrocodone Bitartrate 5 MG Oral Tablet
   
   CAREPLANS:
  2018-12-13 : Allergic disorder monitoring
                         Activity: Allergen immunotherapy (regime/therapy)
  2018-12-13 : Self-care interventions (procedure)
                         Activity: Allergy education
  2014-03-29 : Therapy (regime/therapy)
                         Activity: Physical therapy procedure (regime/therapy)
                         Activity: Cognitive and behavioral therapy (regime/therapy)
   
--------------------------------------------------------------------------------
